🔎 Trials Near Me

Beranda › Penyakit Sel Sabit › Illinois › Chicago

Uji klinis Penyakit Sel Sabit di Chicago, IL

18 studi untuk Penyakit Sel Sabit mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

Menerima pesertaFase 1
  • University of Illinois at Chicago College of Medicine, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT04055818

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Menerima pesertaFase 3
  • Uni of Illinois Hospital and HSC, Chicago
Usia 12 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06439082

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

Menerima pesertaFase 1
  • University of Illinois Hospital and Health Sciences System, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07187973

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Menerima pesertaFase 3
  • Univer Of Illinois at Chicago, Chicago
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

Menerima pesertaFase 3
  • Childrens Hospital of Chicago, Chicago
  • Univer Of Illinois at Chicago, Chicago
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06612268

Tocilizumab for Acute Chest Syndrome

Menerima pesertaFase 2
  • University of Chicago, Chicago
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05640271

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Menerima pesertaFase 1/2Sukarelawan sehat diterima
  • Local Institution - 0034, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06481306

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

Menerima pesertaFase 2/3
  • University of Illinois at Chicago Clinical Research Center, Chicago
  • University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
  • University of Illinois Hospital and Health Sciences System, Chicago
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT05431088

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Menerima pesertaStudi observasional
  • Rush University Medical Center, Chicago
Semua usia · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Menerima pesertaFase 2
  • University of Illinois at Chicago, Chicago
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06699849

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Menerima pesertaFase 3
  • University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
Usia 10 hingga 65 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT06975865

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

Menerima pesertaFase 2
  • University of Illinois at Chicago, Chicago
Usia 16 hingga 60 · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT03121001

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Menerima pesertaStudi observasional
  • Comer Children's Hospital (MRD-HCT), Chicago
Usia 3 hingga 20 · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT06941389

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

Menerima pesertaFase 2
  • University of Illinois Chicago, Sickle Cell Center, Chicago
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT07175051

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

Menerima peserta
  • University of Illinois at Chicago, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Mar 2026 · NCT06919224

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Menerima pesertaFase 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Usia 2 hingga 25 · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT03587272

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Menerima peserta
  • Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Usia 16 hingga 30 · Semua jenis kelamin · Diperbarui 7 Jan 2026 · NCT06374238

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

Menerima pesertaStudi observasional
  • University of Illinois, Chicago
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jun 2025 · NCT06385886

Uji klinis Penyakit Sel Sabit di kota lain

Studi lain di Chicago

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.